Multiple sclerosis (MS) is usually a chronic and disabling inflammatory disease. Marburg’s type of MS is characterized by rapid progression and severe disease course that leads to death within one year after the onset of clinical signs. We describe a fulminant clinical presentation of this malignant subtype of MS and discuss the neuropathological hallmarks as well as differential diagnoses of other fulminant demyelinating diseases. To the best of our knowledge, this is the most fulminant course of this MS variant reported in the literature.
PopescuBFLucchinettiCF. Pathology of demyelinating diseases. Annu Rev Pathol2012; 7: 185–217.
3.
BitschAWegenerCda CostaC. Lesion development in Marburg’s type of acute multiple sclerosis: From inflammation to demyelination. Mult Scler1999; 5: 138–146.
4.
WegnerC. Pathological differences in acute inflammatory demyelinating diseases of the central nervous system. Int MS J2005; 12: 13–19.
5.
BergerJRAksamitAJCliffordDB. PML diagnostic criteria: Consensus statement from the AAN Neuroinfectious Disease Section. Neurology2013; 80: 1430–1438.
6.
YoshidaTNakagawaM. Clinical aspects and pathology of Alexander disease, and morphological and functional alteration of astrocytes induced by GFAP mutation. Neuropathology2012; 32: 440–446.
